Governments Need Better Guidance to Maximise Value for Money: The Case of Australia's Pharmaceutical Benefits Advisory Committee

Drew Carter, Arlene Vogan, Hossein Haji Ali Afzali

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Governments Need Better Guidance to Maximise Value for Money: The Case of Australia's Pharmaceutical Benefits Advisory Committee'. Together they form a unique fingerprint.

Business & Economics

Medicine & Life Sciences

Social Sciences